mitral regurgitation mitral stenosis
Conditions
Interventions
Duration: from the day of surgery to extubation Dose: Dextran 500 ml
Duration: from the day of surgery to extubation Dose: Voluven 500 ml
Duration: from the day of surgery to extubation Dose: None
Sponsors
CHIBA-NISHI GENERAL HOSPITAL
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients undergoing/receiving robotic-assisted valvuloplasty (1 valve) or robotic-assisted valvuloplasty (2 valves). 2) Patients with mitral regurgitation or mitral stenosis. 3) Adult research subjects who have given full explanation of their participation in this study and who have given their or their surrogate's free written consent.
Exclusion criteria
Exclusion criteria: 1) Patients with a CKD score of G4 or higher 2) Dialysis patients 3) Patients undergoing revision surgery 4) Pregnant patients 5) Other patients deemed inappropriate as research subjects by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| fluid balance | — |
Secondary
| Measure | Time frame |
|---|---|
| [Patient Background] Age Gender Height Weight BSA [Preoperative factors] Hb TP Cre [Factors during extracorporeal circulation] Dilution rate (at the start of extracorporeal circulation) Extracorporeal circulation time Aortic blocking time Mean hemoglobin Mean perfusion index Urine output during extracorporeal circulation Blood balance Mannitol usage [Postoperative factors] Intubation time Urine output (during intubation) Max Cre (within 48 hours after surgery) AKI onset existence | — |
Countries
Japan
Contacts
Public ContactMai Shishido
CHIBA-NISHI GENERAL HOSPITAL Clinical Engineering Department
Outcome results
None listed